# Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)

> **NCT04004702** · PHASE2 · UNKNOWN · sponsor: **Walter Reed National Military Medical Center** · enrollment: 65 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT04004702
- **Lead sponsor:** Walter Reed National Military Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2019-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04004702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04004702, "Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04004702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*